SANARX
LIVE

Serial Number

50075719

Owner

MiMedx Group, Inc.

Attorney

Marcy L. Sperry

Filing Date

Aug 27, 2026

Add to watchlist:

No watchlists yet
View on USPTO

SANARX Trademark

Serial Number: 50075719

SANARX is a trademark filed by MiMedx Group, Inc. on August 27, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

MiMedx Group, Inc.

1775 West Oak Commons Ct. NE
Marietta, GA 30062

Entity Type: 03

Trademark Details

Filing Date

August 27, 2026

Registration Date

Not Registered

Goods & Services

Antimicrobial preparations for treating skin and wounds, namely, for preventing and treating infection and eliminating bacteria on human skin and wounds; Bone void fillers consisting of natural materials; Human allograft tissue; Pharmaceutical cleansing preparations used in the treatment of human skin and wounds, namely, preparations for preventing and treating infection, for protecting the skin, and for mechanical cleansing and removal of foreign materials; Medical cleansing preparations used in the treatment of human skin and wounds, namely, preparations for preventing and treating infection, for protecting the skin, and for mechanical cleansing and removal of foreign materials; Medical preparations for use in connection with surgical and wound care; Biological amniotic tissue intended as a soft tissue barrier and wound covering for medical purposes; Biologically derived extracellular matrix material for promoting soft tissue repair and wound healing; Non-medicated preparations consisting of hydrolyzed collagen powder and gel used for the management of wounds, ulcers, and 1st and 2nd degree burns; Allograft based biologics products, namely, an advanced cellular bone matrix for promoting bone formation, excluding wound healing and stem cell products; Biologically derived extracellular matrix material for the management of wounds; Non-medicated wound-healing preparations in the nature of powders used in the management of chronic wounds, namely, wound closure; Non-medicated wound-healing preparations in the nature of gels used in the management of chronic wounds, namely, wound closure; Orthobiologic material primarily consisting of human allograft bone and tissue; Pharmaceutical preparation, namely, collagen for wound care, dental purposes, and the treatment of arthritis; Collagen for use as a dietary supplement; Allografts, namely, human allograft tissue made from human umbilical cords; Allograft made from amniotic material; Human allograft tissue for use as wound dressings; Biologic drugs for treating inflammation and pain using regenerative tissue components; Human biological amniotic membrane tissue intended for subsequent implantation; Human biological chorionic membrane tissue intended for subsequent implantation; Topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment made from chorionic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment made from chorionic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Wound treatment in the nature of a dressing comprising chorionic material; Wound treatment in the nature of a dressing comprising amniotic material; Wound treatment in the nature of a micronized powder comprising amniotic material for medical purposes; Topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Absorbent collagen matrix of Type I and Type III bovine collagen used in the treatment of wounds; Collagen for medical purposes, namely, bovine collagen powder for surgical wound care

Biochemical, namely, collagen for use in the manufacture of nutritional supplements and pharmaceutical preparations

Research and development of treatments for skin care, wound care, and surgical care; Development of medical preparations for use in connection with surgical and wound care

Cleaning, disinfection, and drying of human biological membrane tissue intended for subsequent hydration and surgical implantation

Synthetic bone grafts; Medical device, namely, a device for applying collagen powder to surgical wounds

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 27, 2026 MAFR
NEW APPLICATION ENTERED
Aug 27, 2026 NWAP